Sunrest Lifescience Ltd.
National Stock Exchange of IndiaTotal Valuation
Sunrest Lifescience Ltd. carries a market capitalization of 152.77M, placing it among publicly traded companies globally.
| Market Cap | 152.77M |
| Enterprise Value | N/A |
Financial Position
Sunrest Lifescience Ltd. maintains a current ratio of 4.97, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 265.55, indicating elevated leverage, while an interest coverage ratio of 44.11 demonstrates strong ability to service its debt obligations.
| Current Ratio | 4.97 |
| Quick Ratio | 0.18 |
| Debt / Equity | 265.55 |
| Debt / EBITDA | N/A |
| Interest Coverage | 44.11 |
Taxes
Over the trailing twelve months, Sunrest Lifescience Ltd. has paid -4.25M in income taxes, reflecting an effective tax rate of 22.92.
| Income Tax | -4.25M |
| Effective Tax Rate | 22.92 |
Stock Price Statistics
Sunrest Lifescience Ltd.'s stock has declined approximately -29.36508% over the past 52 weeks. The 50-day moving average sits at 36.27, while the 200-day moving average is 43.15.
| Beta (5Y) | N/A |
| 52-Week Price Change | -29.36508% |
| 50-Day Moving Average | 36.27 |
| 200-Day Moving Average | 43.15 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Sunrest Lifescience Ltd. generated 188.78M in revenue and converted that into 16.65M in net income, yielding earnings per share of 3.46. EBITDA reached 12.40M, while operating income came in at 12.40M.
| Revenue | 188.78M |
| Gross Profit | 73.86M |
| Operating Income | 12.40M |
| Pretax Income | 12.41M |
| Net Income | 16.65M |
| EBITDA | 12.40M |
| EBIT | 12.40M |
| Earnings Per Share (EPS) | 3.46 |
Cash Flow
Sunrest Lifescience Ltd. produced 2.96M in operating cash flow over the past twelve months. After subtracting -67,000.00 in capital expenditures, free cash flow totaled 2.90M - equivalent to 0.60 per share.
| Operating Cash Flow | 2.96M |
| Capital Expenditures | -67,000.00 |
| Free Cash Flow | 2.90M |
| FCF Per Share | 0.60 |
Margins
Sunrest Lifescience Ltd. operates with a gross margin of 39.13, reflecting its pricing power and cost economics. The operating margin of 6.57 and net profit margin of 8.82 provide insight into operational efficiency.
| Gross Margin | 39.13 |
| Operating Margin | 6.57 |
| Pretax Margin | 6.57 |
| Profit Margin | 8.82 |
| EBITDA Margin | 6.57 |